Machine Learning Risk Stratification Approach Using Patient-Reported Outcomes for Forecasting Unplanned Health Care Use and Symptom Burden in Cancer Survivors

View at publisher
Authors: Akina Natori, Jerry R. Bonnell, Vasileios Stathias, Sara E. Fleszar‐Pavlović, Mitsunori Ogihara, Andrew Wang, Ravi Vadapalli, Blanca S. Noriega Esquives, Tracy E. Crane, Frank J. Penedo
Cited by: 1
References: 33

Abstract

PURPOSE Effective risk stratification in cancer survivorship requires handling longitudinal data characterized by multimodal inputs, irregular follow-up, and recurrent clinical events. This study evaluated the incremental value of integrating patient-reported outcomes (PROs) with electronic health record (EHR) data and identified optimal windowing strategies for machine learning–based prediction of adverse survivorship outcomes. PATIENTS AND METHODS This study used a cohort of 25,592 cancer survivors followed for 36 months. Data from four domains were integrated: baseline measures, treatments, PROs, and health care utilization (emergency room visits and hospitalizations). Two classification models, LASSO and CATBOOST, were applied across modality combinations and five temporal representations of patient history: static early-phase (0-6 months), cumulative history, sliding windows (4- and 12-month), and a most-recent baseline. Performance was evaluated for predicting monthly health care utilization and patient-reported symptom burden using average precision (AP). SHapley Additive exPlanations (SHAP) analysis identified key predictors and characterized their evolving influence. RESULTS For health care utilization, CATBOOST models trained on the full multimodal data set with time-windowed predictors achieved strong discrimination (AP = 0.207), outperforming static baselines by 27%. SHAP analyses emphasized dynamic contributions from recent utilization and treatment toxicity. For symptom burden, PRO integration was crucial, nearly doubling clinical-only performance (AP = 0.132 v 0.071), with longer historical context improving characterization of progressive functional decline and symptom severity. Flagging the top 10% of patients by predicted risk captured 51.7% of health care utilizations and 46.7% of symptom burden events. CONCLUSION Adverse survivorship risk is dynamic and outcome-specific: acute health care utilization is best predicted by recent clinical momentum, while longitudinal patient-reported trends drive symptom burden. Implementing decoupled, dynamic windows provides a flexible framework for risk stratification and risk prediction beyond standard clinical heuristics, facilitating proactive, precision-based survivorship care.

Fields of Study & Subjects

Cancer survivorship and care Machine Learning in Healthcare Cancer-related cognitive impairment studies

Publication details

Journal / source
JCO Clinical Cancer Informatics
Publisher
American Society of Clinical Oncology (ASCO)
Volume
10
Issue
2
Pages
e2500389–e2500389
Publication date
1 April 2026
Language
EN